Cite
HARVARD Citation
Kosiborod, M. et al. (2018). Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study. Diabetes, obesity & metabolism. 20 (8), pp. 1983-1987. [Online].